Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Setback for Roche as schizophrenia candidate fails studies

Setback for Roche as schizophrenia candidate fails studies Abilify (aripiprazole) lost patent protection and succumbed to generic competition.

Ipragliflozin beats diabetes rivals to Japanese approval

Ipragliflozin beats diabetes rivals to Japanese approval 2010. - Otsuka Pharmaceutical has filed for approval of its once-monthly intramuscular formulation of antipsychotic Abilify (aripiprazole) as a maintenance treatment for schizophrenia. ... The product was launched in the US last year under the Abilify

Profits down at Lundbeck as revenues slip

Profits down at Lundbeck as revenues slip and depot antipsychotic Abilify Maintena (aripiprazole). ... Lundbeck said uptake of Abilify Maintena is "encouraging", although it did not break out sales figure for the drug, which reached the US market in March 2013 and has been recommended

Pharma deals during September 2013

Pharma deals during September 2013 Otsuka is focused on filling the gap to be left once its leading product antipsychotic blockbuster Abilify, comes off patent, imminently.

Lundbeck buoyed by Brintellix approval in US

Lundbeck buoyed by Brintellix approval in US Beyond Brintellix, Lundbeck is counting on its once-monthly antipsychotic Abilify (aripiprazole) and alcohol dependency treatment Selincro (nalmefene) to take it back to historical growth rates. ... Meanwhile, Lundbeck also has two projects in phase III

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics